Prism Medico and Pharmacy share news, announcements and annual reports
Share price at the BSE close on 30 Oct 2026. Previous close ₹35.80.
30 Oct: open ₹34.52, high ₹36.60, low ₹34.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹48 Cr4,315th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 42,981
Prism Medico and Pharmacy share news and announcements
818 announcements, routine notices left out, newest first. Page 10 of 17.
Sep 2019
5 Sep · Announcement under Regulation 30 (LODR)-Meeting Updates
5 Sep · NOTICE AND ANNUAL REPORT FOR THE FINANCIAL YEAR ENDED 31St March, 2019
Aug 2019
22 Aug · Board meeting
Meeting on 30 Aug 2019: annual general meeting9 Aug · Board meeting
Meeting on 13 Aug 2019: quarterly results
Jul 2019
20 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....9 Jul · Regulation 13(3)-Statement Of Investor Complaints For The Quarter Ended On 30Th June, 2019
9 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2019
10 Jun · Board meeting
Meeting on 17 Jun 20193 Jun · NON APPLICABILITY Of DISCLOSURE UNDER REGULATION 23(9) Of SEBI LODR
3 Jun · Non Applicability Of Regulation 23 (9) Of SEBI (LODR) Regulations, 2015
May 2019
30 May · RESULT FOR YEAR ENDED 31.03.2019
20 May · Board meeting
Meeting on 30 May 2019: audited results
Apr 2019
27 Apr · Submission Of Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended On 31St March, 2019
18 Apr · Board meeting
Meeting on 25 Apr 20199 Apr · Shareholding for the Period Ended March 31, 2019
Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....8 Apr · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended On 31St March, 2019
8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2019
26 Mar · Board meeting
Meeting on 30 Mar 2019
Feb 2019